Heather Gerrish

Heather Gerrish is a Clinical Research Nurse at Yale School of Medicine, contributing to oncology and immunotherapy research. Her work focuses on clinical trials for non-small cell lung cancer (NSCLC) and melanoma, particularly examining pembrolizumab's efficacy in brain metastases cases. She collaborates with prominent researchers like Roy Herbst, Scott Gettinger, and Anne Chiang.

Research interests include biomarker analysis, immune checkpoint inhibitors, and long-term outcomes of immunotherapy in metastatic cancers. Her publications highlight durability of response, patient survival rates, and combination therapies for NSCLC.

Her recent articles explore trends in immuno-oncology, covering monoclonal antibody therapy (e.g., Anti-Siglec-15), clinical trial design, and patient outcome monitoring in NSCLC. These studies emphasize translational research applications and cancer therapy innovation.

No scientific awards are explicitly mentioned in the provided data.

Heather's role involves clinical investigation, trial coordination, and data analysis for advanced non-small cell lung cancer treatments. She works within interdisciplinary teams at Yale, including the Yale Cancer Center and Yale Center for Clinical Investigation.